Award recordCONTRACT

ABBVIE US LLC

PIID 36C24921N0193· VHA· 249-NETWORK CONTRACT OFFICE 9 (36C249)· 6505 · DRUGS AND BIOLOGICALS· FY2021· $12,848 net obligations· UEI MAB9Y43Z1US6· IL

Description

CARBIDOPA 4.63 LEVODOPA 20MG/ML INTERNAL SUSPENSION

First action · last action
2020-11-25 · 2020-11-25
Transactions
1
First transaction's obligation
$12,848
Base + all options value (sum of deltas)
$12,848
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79718D0528
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$12,848$0Base award · 2020-11-25 · this action $12,848 · running total $12,848
  • Base2020-11-25+$12,848= $12,848
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2020-11-25+$12,848$12,848CARBIDOPA 4.63 LEVODOPA 20MG/ML INTERNAL SUSPENSION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI MAB9Y43Z1US6)

AwardOffice · PSC / listingNet obligationsFY
36C26226P0366262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$3,317FY2026
36C26226P0330262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$1,432FY2026
36C26226P0199262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$21,573FY2026
36C26026F0021260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$113,265FY2026
36C26026F0020260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$41,534FY2026
36E79725A0024NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025

Other recipients under 6505 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24926N0676AMICUS THERAPEUTICS US, LLC249-NETWORK CONTRACT OFFICE 9 (36C249)$68,519FY2026
36C24926N0651BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$378,650FY2026
36C24926N0658BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0590BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0589BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24921N0193_3600_36F79718D0528_3600 · retrieved 2026-09-26.